Darunavir en pacientes avanzados con multirresistencias. Estudios POWER, DUET y BENCHMRK

Arazo Garcés, Piedad; Omiste Sanvicente, Teresa.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 26(supl.10): 23-31, oct. 2008. ilus
Artículo en Es | IBECS (España) | ID: ibc-71206

Documentos relacionados

  1. Darunavir en pacientes avanzados con multirresistencias. Estudios POWER, DUET y BENCHMRK
  2. CROI 2019: advances in antiretroviral therapy.
  3. HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.
  4. Achilles heel spotted for promising HIV-prevention drug.
  5. Los estudios de resistencias a antirretrovirales como herramienta para el análisis de los clusters de transmisión del virus de la inmunodeficiencia humana
  6. Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trial.
  7. Safety and Efficacy of Ledipasvir-Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6-11.
  8. Twice-Daily Dosing of Dolutegravir in Infants on Rifampicin Treatment: A Pharmacokinetic Substudy of the EMPIRICAL Trial.
  9. Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia.
  10. Drug resistance pattern among ART-naive clients attending an HIV testing and counseling center in Dhaka, Bangladesh.